Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 5 Neoplasms 3 Colorectal Neoplasms 3 Multiple Myeloma 2 Melanoma 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Sarcoma, Myeloid 1 Sarcoma 1 Rhabdoid Tumor 1 Pyloric Stenosis, Hypertrophic 1 Prostatic Neoplasms 1 Polycythemia Vera 1 Parkinsonian Disorders 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lymphoma 1 Lung Neoplasms 1 Kidney Neoplasms 1 Histiocytoma, Malignant Fibrous 1 High Grade Neuroendocrine Neoplasms 1

Interventions

upadacitinib 1 Vaccines 1 Saline Solution 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Herpes Zoster Vaccine 1 Collagenases 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Arthritis × Blood Specimen Collection × Clear all

NCT07284563 2025-12-16

Ultralow Dose PET Imaging for 18F-NaF Uptake

Nuclear Imaging Institute

Phase 2 Recruiting

Arthritis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡